Clinical Trials Directory

Trials / Completed

CompletedNCT04761757

Antidepressant Decision Aid for Major Depressive Disorder Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
752 (actual)
Sponsor
University of Malaya · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether Antidepressant Decision Aid for Major Depressive Disorder is feasible and effective in involving patients in the decision-making process when initiating pharmacotherapy.

Detailed description

To examine the ability of the patient decision aid to enhance shared decision making and preparedness to make decisions pertaining to antidepressant therapy. The research team has systematically developed an Antidepressant Decision Aid for Major depressive disorder patients (ADAM) according to the International Patient Decision Aids Standards (IPDAS) and the Ottawa Decision Support Framework. This is a posttest-only study with nonequivalent groups to evaluate the effect of the antidepressant decision aid on patient and physician perception of shared decision making as well as patient preparedness for making pharmacotherapeutic decisions compared usual care.

Conditions

Interventions

TypeNameDescription
OTHERBooklet of Scripts of DoctorsThe "Booklet of Scripts for Doctors" was used in the control arm. This tool was developed and tested to encourage shared decision-making in prescribing antidepressants within the Malaysian context.
OTHERBooklet of Scripts for Doctors and the Antidepressant Decision Aid for Major depressive disorder patients (ADAM)The "Booklet of Scripts for Doctors" along with the "Antidepressant Decision Aid for Major depressive disorder patients, ADAM", was used in the intervention arm. The decision aid was developed as per the International Patient Decision Aid Standards (IPDAS) criteria to enhance patient understanding of risks and benefits of different antidepressants available within the Malaysian context.

Timeline

Start date
2019-12-01
Primary completion
2020-10-30
Completion
2020-10-30
First posted
2021-02-21
Last updated
2021-02-21

Locations

17 sites across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT04761757. Inclusion in this directory is not an endorsement.